Intravenous immunoglobulin therapy and systemic lupus erythematosus.
about
Lupus nephritis: current updateThe Production Processes and Biological Effects of Intravenous ImmunoglobulinHematological features of pediatric systemic lupus erythematosus: suggesting management strategies in children.Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.Biologic therapy for autoimmune diseases: an update.Intravenous immunoglobulin in the management of lupus nephritis.Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology.Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.Lupus activity in pregnancyA case of mistaken identity: When lupus masquerades as primary myelofibrosis.Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside.NK cells, autoantibodies, and immunologic infertility: a complex interplay.Update on emerging drug therapies for systemic lupus erythematosus.Accessing the human repertoire for broadly neutralizing HIV antibodies.The steroid-sparing effect of intravenous immunoglobulin in patients with autoimmune diseases.Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science.Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.Acute longitudinal myelitis following Cryptococcus laurentii pneumonia in a patient with systemic lupus erythematosus.Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus.Triple threat in pregnancy.
P2860
Q22000837-7DBE5E00-D7C0-451D-AAE4-287A9CD8C56EQ26752540-61B48E60-2D8E-4307-9875-8507BC509DC3Q33400710-3B5A88F3-F2B1-4026-894E-C2028107B7AFQ33407247-9A48AA68-FD9F-43DA-BC15-350E48B7A917Q34655597-18C68CD3-A692-4223-B867-C22353CF8FF3Q36302368-1064069F-823B-43C8-9E0E-C1DF6561CA7FQ36711702-42C16E46-A49A-43CA-93BF-3828E1400809Q36794149-1DC36DCE-77D5-4440-8719-3AF26962EBBBQ36820979-F2DD2AF3-9BC5-40BB-A6F5-A0AA0714AEDEQ36871360-BEEB5B07-75C3-46ED-B73D-EC8AC96ECE0FQ37578120-C6E7D411-48A6-42E9-94D3-37FC4AAC1B5EQ37631529-C759C7D7-3380-4AD0-87D0-D6903950128BQ37690745-9741679D-C5E4-4E50-B87C-432963E32A67Q37694976-BA593345-4328-4005-A393-E1B481D8219AQ37754661-1CED2250-C065-4C2F-830B-0BA874FB844EQ37773248-2F9F38D4-8795-4410-9FD4-D31EDE425062Q37954539-E6EC8398-ADA7-40E8-8D4D-EC710FEDF2A1Q41710244-4496B616-0ABC-4BCA-95E4-78A94ACFF54CQ48354790-C0788F9C-F25C-473D-BFA0-4845B75EF6B9Q51431847-4528A650-48B3-49CB-8F75-CCE181F10838
P2860
Intravenous immunoglobulin therapy and systemic lupus erythematosus.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Intravenous immunoglobulin therapy and systemic lupus erythematosus.
@ast
Intravenous immunoglobulin therapy and systemic lupus erythematosus.
@en
type
label
Intravenous immunoglobulin therapy and systemic lupus erythematosus.
@ast
Intravenous immunoglobulin therapy and systemic lupus erythematosus.
@en
prefLabel
Intravenous immunoglobulin therapy and systemic lupus erythematosus.
@ast
Intravenous immunoglobulin therapy and systemic lupus erythematosus.
@en
P50
P356
P1476
Intravenous immunoglobulin therapy and systemic lupus erythematosus.
@en
P2888
P304
P356
10.1385/CRIAI:29:3:219
P577
2005-12-01T00:00:00Z
P5875
P6179
1003915573